381
Participants
Start Date
November 30, 2008
Primary Completion Date
April 30, 2009
Study Completion Date
May 31, 2009
NT 201 (IncobotulinumtoxinA (Xeomin®/Bocouture®))
NT201, also known as IncobotulinumtoxinA (Xeomin®/Bocouture®), active ingredient: Clostridium botulinum neurotoxin type A free from complexing proteins, powder for solution for injection dose, 24 units; one injection session of solution, prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl). Of the 0.6 mL total injection volume, an aliquot of 0.15 mL was administered in the procerus muscle, aliquots of 0.125 mL were administered in the medial part of the both corrugator muscles and aliquots of 0.1 mL were administered in the middle part of both corrugator muscles.
OnabotulinumtoxinA (Vistabel®)
OnabotulinumtoxinA (Vistabel®), active ingredient: Clostridium botulinum neurotoxin type A, powder for solution for injection dose, 24 units; one injection session of solution, prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl). Of the 0.6 mL total injection volume, an aliquot of 0.15 mL was administered in the procerus muscle, aliquots of 0.125 mL were administered in the medial part of the both corrugator muscles and aliquots of 0.1 mL were administered in the middle part of both corrugator muscles.
Baden
Krems
Salzburg
Vienna
Bad Soden
Böblingen
Cologne
Darmstadt
Frankfurt
Korschenbroich
Ludwigshafen
Munich
Wuppertal
Glasgow
Manchester
Suttion Coldfield
Winchester
Lead Sponsor
Merz Pharmaceuticals GmbH
INDUSTRY